★ PREMIUM
Health
US approves first drug treatment for sleep apnea
Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood pressure.
Zepbound is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood pressure. (AFP)
By: NewVision Reporter, Journalist @NewVision
WASHINGTON - US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of